Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

Paul Nowatzki, Bayer MaterialScience to Speak at Biobased Chemicals Conf. Sep 13-14, 2012 in SF, CA

GTC
Posted on: 09 Jul 12

Paul Nowatzki, Ph.D., Senior Associate Scientist and Innovation Manager at Bayer MaterialScience will give a Presentation entitled, “Polymer Company Perspective on Biobased Chemicals: Opportunities and Challenges” at the 3rd Biobased Chemicals: Commercialization & Partnering Conference on September 13-14, 2012 in San Francisco, CA.

Bayer MaterialScience is committed to sustainable development, and biobased chemicals are one means of addressing this topic. Biobased projects can also represent interesting business opportunities. Bayer MaterialScience’s intermediate position on the value chain, between refiners and end-product manufacturers, gives it a unique perspective on biobased partnering.

Dr. Nowatzki will discuss what motivates Bayer to work on biobased chemicals, the advantages and disadvantages of different types of chemicals/biobased partnerships, Bayer’s criteria to evaluate partners and projects, and the challenges faced to date in implementing biobased chemicals.

GTC’s 3rd Biobased Chemicalse Commercialization & Partnering Conference will bring together the top companies and experts together to examine new supply chain developments and business models being adopted for bringing biobased chemicals products to market. The session topics include novel chemical production platforms, advantageous feedstock, end user applications, securing funding & strategic partnerships, trends & challenges in commercial scale up.

Presenting will be Top Executive Speakers from the following Companies: Amyris, BASF, Bayer MaterialScience LLC., CBiRC, Ceres, Inc., Chemtex, Codexis, DSM, DSM Venturing, Flagship Ventures, Genomatica, Gevo, LanzaTech, Ls 9, Lux Research, Myriant Corporation, OPX Biotechnologies, Proterro, Segetis, Solazyme, The Dow Chemical Company, USDA, Agricultural Research Service, Western Regional Research Center, USDA, Environmental Managment Division (EMD), Verdezyne, Virdia, Virent, ZeaChem and many more!

To view the Program Agenda Click Here. For more information, please visit www.gtcbio.com

For more information:
http://www.gtcbio.com/index.php?option=com_conference&file=program&cn=3rd%20Biobased%20Chemicals:%20Commercialization%20&cid=92

Editor's Details

Ken Lin
GTC
http://635 W. Foothill Blvd Monrovia, CA 91016
6262566405
ken.lin@gtcbio.com

Last updated on: 09/07/2012

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.